CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy

PURPOSE: While tumor markers (carbohydrate antigen 19-9 [CA 19-9] and carcinoembryonic antigen [CEA]) can aid in the diagnosis of biliary tract cancer, their prognostic role has not been clearly elucidated. Therefore, this study was conducted to evaluate the prognostic role of tumor markers and tumo...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancer Res Treat
Prif Awduron: Lee, Dae-Won, Im, Seock-Ah, Kim, Yu Jung, Yang, Yaewon, Rhee, Jiyoung, Na, Im Il, Lee, Kyung-Hun, Kim, Tae-Yong, Han, Sae-Won, Choi, In Sil, Oh, Do-Youn, Kim, Jee Hyun, Kim, Tae-You, Bang, Yung-Jue
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Korean Cancer Association 2017
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5512384/
https://ncbi.nlm.nih.gov/pubmed/28111425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2016.326
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg